Mifestad 200

Mifepristone is a synthetic steroid with an antiprogestational action as a result of competition with progesterone at the progesterone receptors.

Pack size Box of 1 tablet, 10 tablets.
Shelf-life 36 months
Composition Mifepristone
Dosage forms and strengths Tablet: 200 mg
Product code :



Ending an early pregnancy by medical methods (medication abortion) strictly following the current “National Guidance on Reproductive Health Care Services” issued by the Minister of Health’s.


1 tablet of Mifestad 200 (equivalent to 200 mg of mifepristone) is taken. 48 hours thereafter, take 400 mcg misoprostol. Take analgesics such as paracetamol or ibuprofen if necessary. Within two weeks after taking Mifestad 200 tablets, the patient should revisit the hospital.


Mifestad 200 is orally administered.

  • Known hypersensitivity to prostaglandin or to the active substance or excipients.
  • The pregnancy has already passed the 49 day.
  • Pregnancy not verified by ultrasound scanning or biochemical tests.
  • Confirmed or suspected ectopic pregnancy.
  • Patients with renal or hepatic impairment.
  • Concurrent long-term corticosteroid therapy.
  • Hemorrhagic disorder or concurrent using anticoagulant therapy.
  • Patient is or used to be suffering from any cardiovascular diseases or disorders (angina pectoris, Raynaud’s disease of syndrome, irregular pulse, heart failure and severe hypertension).
  • Woman with age over 35 and smoking more than 10 cigarettes per day.
  • Hereditary porphyria.

Vaginal bleeding, feels stomach sick, displays vomiting, and diarrhoea symptoms, hypotension.

  • The intrauterine device must be removed prior to the administration of Mifestad 200.
  • If a patient only use Mifestad 200 alone (without the subsequent taking of misoprostole), failure rate will be higher. If the method does fail, there is a risk to deliver a deformed baby later. In case this method does fail, it is a must to use another method to terminate the pregnancy in the next follow-up visit the hospital.
  • Almost all women to use this method for having an abortion will have long lasting vaginal bleeding phenomenon (from 3 to 21 days). The bleeding does not necessary represent that gestation tissue has been completely expelled. Right after taking misoprostole, the patient should stay at the hospital for 3 hours for observation.
  • Mifestad 200 should be given with care to patients with less severe asthma or with chronic obstructive airways diseases, haemorrhagic or cardiovascular disease or associated risk factors, or anemia.
  • The routine dose of corticosteroids may need temporary adjustment during the 3-4 days after taking Mifestad 200. For those using inhaling type of corticosteroids, especially asthma patients, it is recommended that somewhere about 48 hours after taking mifepristone, the dose should be adjusted to double the original amount and kept there for one week.
  • Readjust the insulin dose for patient of young age diabetes, if there is a gastrointestinal problem showing up.
  • Patients with prosthetic heart valves or those with a history of infective endocarditis should be given chemoprophylaxis when undergoing pregnancy termination.
  • Rhesus-negative women who have not been rhesus immunized will require protection with anti-D immunoglobulin.
  • After taking Mifestad 200, the patient should stop nursing for 3-4 days.